Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients.
Tan Q, Wang D, Yang J, Xing P, Yang S, Li Y, Qin Y, He X, Liu Y, Zhou S, Duan H, Liang T, Wang H, Wang Y, Jiang S, Zhao F, Zhong Q, Zhou Y, Wang S, Dai J, Yao J, Wu D, Zhang Z, Sun Y, Han X, Yu X, Shi Y.
Tan Q, et al. Among authors: yu x.
Theranostics. 2020 May 16;10(14):6399-6410. doi: 10.7150/thno.45816. eCollection 2020.
Theranostics. 2020.
PMID: 32483460
Free PMC article.